Bromocriptine therapy in eleven patients with acromegaly
Lundin, L.; Ljunghall, S.; Wide, L.; Boström, H.
Acta Endocrinologica. Supplementum 216: 207-216
1978
ISSN/ISBN: 0300-9750 PMID: 347863 Document Number: 135934
Eleven patients with active acromegaly were treated with bromocriptine for one year or more. Nine showed significant reduction in plasma growth hormone levels and eight improvement with respect to clinical symptoms. No serious side effects were observed.
Document emailed within 1 workday
Related Documents
Barceló, B.; Pérez, C.; Dávila, N.; Lucas, T.; Salto, L.; Alcañiz, J. 1983: Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both Medicina Clinica 80(17): 735-741Jaedig, S. 1982: Medical treatment of acromegaly with bromocriptine Ugeskrift for Laeger 144(47): 3514-3515
Nilsson, A. 1978: Experiences with bromocriptine treatment in acromegaly--a preliminary report Acta Endocrinologica. Supplementum 216: 217-224
Besser, G.M.; Wass, J.A. 1978: Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years Medical Journal of Australia 2(3 Suppl): 31-33
Ryzhakov, B.A.; Nuller, I.U. 1992: The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(3): 79-80
Campagnoli, C.; Belforte, L.; Bruno, M.; Fessia, L.; Pinna, N.; Massara, F. 1980: Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea Minerva Ginecologica 32(5): 400-404
Teubner, A.; Breidert, M.; Baehring, T.; Hensen, J.; Bornstein, S.R. 1997: Clinical picture, diagnosis and therapy of acromegaly patients in Eastern and Western Germany Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(8): 739-745
Ho, K.Y.; Smythe, G.A.; Compton, P.J.; Lazarus, L. 1985: Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia Australian and New Zealand Journal of Medicine 15(2): 213-219
Niwa, J.; Tanabe, S.; Hashi, K. 1996: Seizures as a late complication of bromocriptine therapy in patients with prolactin-producing macroadenomas: correlation between lateral extension of the adenoma and seizure onset No Shinkei Geka. Neurological Surgery 24(10): 913-919
Buvat, J.; Buvat-Herbaut, M. 1982: Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(4): 509-521
Friesen, H.G. 1980: Bromocriptine therapy of hyperprolactinemic disorders Advances in Biochemical Psychopharmacology 23: 147-154
Von Werder, K.; Eversmann, T.; Fahlbusch, R.; Rjosk, H.K. 1978: Drug therapy of hyperprolactinemia and acromegaly Acta Medica Austriaca 5(3): 61-63
Klimek, R. 1983: Short-term bromocriptine therapy in female infertility Ginekologia Polska 54(6): 397-400
Tyson, D.; Reggiardo, D.; Sklar, C.; David, R. 1993: Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy American Journal of Diseases of Children 147(10): 1057-1061
Landgraf, R.; Landgraf-Leurs, M.M.; von Werder, K.; Scriba, P.C. 1976: Therapy of the diabetic metabolic condition in hyperprolactinemias and acromegaly Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1915-1917
Trainer, P.J. 2003: Lessons from 6 years of GH receptor antagonist therapy for acromegaly Journal of endocrinological investigation 26(10 Suppl): 44-52
Takahashi, T.; Kuwayama, A.; Katoh, T.; Ichihara, K.; Kageyama, N.; Sasaki, F. 1984: Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report No Shinkei Geka. Neurological Surgery 12(1): 71-80
Saie, D.J.; Sills, E.S. 2005: Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology Neuro Endocrinology Letters 26(5): 533-535
Bolanowski, M.; Bar-Andziak, E.; Kos-Kudła, B.; Krzyzanowska-Swiniarska, B.; Lewiński, A.; Łomna-Bogdanov, E.; Milewicz, A.; Sowiński, J.; Zgliczyński, W. 2008: Consensus statement of the Polish Society for Endocrinology: presurgical somatostatin analogs therapy in acromegaly Neuro Endocrinology Letters 29(1): 59-62
Takahashi, H.; Takahashi, Y.; Mine, J.; Mukaida, S.; Ikegami, M.; Ikeda, H.; Ohtani, H.; Shimomura, J.; Kubota, Y.; Fujiwara, T. 2010: Effectiveness of topiramate in eleven patients with Dravet syndrome No to Hattatsu 42(4): 273-276